Search

Author/Creator Shoji, Shingo

1. Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world administrative database study in Japan. Issue 3 (14th December 2022)

Authors:
Kashiwagi, Atsunori; Shoji, Shingo; Kosakai, Yoshinori; Koga, Tadashi; Asakawa, Keiko; Rokuda, Mitsuhiro
Journal:
Journal of diabetes investigation
Issue:
Volume 14:Issue 3(2023)
Page Start:
404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis. (August 2022)

Authors:
Abiru, Norio; Shoji, Shingo; Kosakai, Yoshinori; Snijder, Robert; Asakawa, Keiko; Rokuda, Mitsuhiro
Journal:
Diabetes research and clinical practice
Issue:
Volume 190(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world retrospective administrative database analysis in Japan. Issue 7 (9th April 2022)

Authors:
Kashiwagi, Atsunori; Shoji, Shingo; Onozawa, Satoshi; Kosakai, Yoshinori; Waratani, Miina; Ito, Yuichiro
Journal:
Journal of diabetes investigation
Issue:
Volume 13:Issue 7(2022)
Page Start:
1175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗